Relistor

• Relistor (methylnaltrexone) is a prescription medication designed to treat opioid-induced constipation.
• It functions as a peripherally acting mu-opioid receptor antagonist, blocking the constipating effects of opioids in the gut.
• Relistor is available in both injectable and oral forms, with dosage tailored to individual patient needs and medical conditions.
• Common side effects can include abdominal pain, nausea, diarrhea, and dizziness.
• It is crucial to use Relistor under medical supervision, adhering strictly to prescribed dosages and understanding its potential interactions.

What is Relistor and How it Works

what is Relistor? Relistor is the brand name for methylnaltrexone, a medication specifically formulated to address opioid-induced constipation (OIC). OIC is a common and often debilitating side effect experienced by individuals taking opioid medications for chronic pain or palliative care, as opioids can slow down bowel movements significantly. Unlike traditional laxatives, Relistor works through a distinct mechanism to alleviate this condition.

How does Relistor work? Relistor functions as a peripherally acting mu-opioid receptor antagonist. This means it blocks the effects of opioids specifically in the gastrointestinal tract, without crossing the blood-brain barrier in significant amounts. By doing so, it counteracts the constipating effects of opioids on the bowel while allowing the opioids to continue providing pain relief centrally. This targeted action helps restore normal bowel function in patients suffering from OIC, offering relief from symptoms such as straining, hard stools, and infrequent bowel movements.

Relistor Uses, Dosage, and Potential Side Effects

What is Relistor used for? Relistor is indicated for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain or advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. It is not intended for the treatment of constipation not caused by opioids. The decision to use Relistor should be made by a healthcare professional after assessing the patient’s condition and history of OIC.

Relistor medication information indicates that it is available in two primary forms: a subcutaneous injection and an oral tablet. The dosage and administration method depend on the patient’s specific needs, kidney function, and the form of the medication prescribed. For instance, the injectable form is typically administered once daily or every other day, while the oral tablets are usually taken once daily. It is critical for patients to follow their healthcare provider’s instructions precisely regarding dose and frequency to ensure optimal effectiveness and minimize risks.

Like all medications, Relistor can cause Relistor side effects. Common side effects often include:

• Abdominal pain or discomfort
• Nausea
• Diarrhea
• Flatulence
• Dizziness
• Sweating

More serious, though less common, side effects can include severe abdominal pain, signs of gastrointestinal perforation (such as fever, chills, or persistent severe abdominal pain), or allergic reactions. Patients should contact their doctor immediately if they experience any severe or persistent side effects. Before starting Relistor, patients should discuss their full medical history, including any existing gastrointestinal conditions or other medications they are taking, with their healthcare provider to ensure it is a safe and appropriate treatment option.